| Views | |
|---|---|
| Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression | 272 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression | 2 | 6 | 17 | 33 | 10 | 15 | 10 |
| Views | |
|---|---|
| 2020_ Elkilany_etal.pdf | 141 |